Skip to main content

Retail Clinics

  • Study: Vitamin D supplementation saves lives

    KANSAS CITY, Kan. — A study published online earlier this month by the American Journal of Cardiology concluded that supplementation with vitamin D conferred substantial survival benefits, specifically in patients with documented deficiency.

    According to the research, evidence supported an association between vitamin D deficiency and hypertension, peripheral vascular disease, diabetes mellitus, metabolic syndrome, coronary artery disease and heart failure.

  • Performance Health introduces Perform Pain Relieving Spray

    AKRON, Ohio — Performance Health announced the availability of Perform Pain Relieving Spray, a solution for applying cold therapy to hard-to-reach areas.

  • Perrigo gains approval for store brand Mucinex

    ALLEGAN, Mich. — Perrigo on Monday announced that it received final approval from the Food and Drug Administration for its store-brand version of Mucinex tablets.

    Perrigo is still in litigation with Reckitt Benckiser involving the introduction of a private-label Mucinex. "Perrigo is working through the litigation and expects to begin shipping this product in our retail and wholesale customers' store brand packaging in the second half of our fiscal year," Perrigo chairman and CEO Joseph Papa said.

  • CDC: Elderly patients at risk of emergency hospitalizations from blood thinners, diabetes medications

    ATLANTA — Many elderly patients put themselves at risk for emergency hospitalization due to adverse drug events, according to a new Centers for Disease Control and Prevention study published in the New England Journal of Medicine.

  • PatientsLikeMe to introduce daily blood-glucose monitoring feature

    CAMBRIDGE, Mass. — An online data sharing platform announced it will debut a daily blood-glucose monitoring feature for its more than 2,000 diabetes patients.

    PatientsLikeMe said patients will be able to report daily glucose levels, as well as continue sharing and learning from HbA1C scores, treatments and dosages, in addition to symptoms and severity.

    The feature will be launched in early December, PatientsLikeMe said.

  • FDA approves Medtronic continuous glucose monitoring system

    MINNEAPOLIS — The Food and Drug Administration has approved a professional glucose monitoring system made by Medtronic, the company said.

  • FDA approves first drug for insomnia with middle-of-night waking, difficulty returning to sleep

    SILVER SPRING, Md. — The Food and Drug Administration has approved the first drug for insomnia in which patients wake in the middle of the night and have trouble returning to sleep.

  • Study: Diabetes dashboard may help physicians better deliver care to patients

    COLUMBIA, Mo. — A new tool developed by researchers at the University of Missouri improved both the efficiency and accuracy of acquiring data needed for high-quality diabetes care, according to a new study.

X
This ad will auto-close in 10 seconds